Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.

Oncology (Williston Park, N.Y.)

Volumn 23, Issue 2 Suppl 1, 2009, Pages 18-25

  Cmelak, Anthony J ^a   Lordick, Florian ^a   Borner, Markus ^a   Goldberg, Richard M ^a   Saif, M Wasif ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; EUROPE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NEOPLASM; REVIEW; UNITED STATES;

ANAPHYLAXIS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; EUROPE; HUMANS; INFUSIONS, INTRAVENOUS; NEOPLASMS; UNITED STATES;

EID: 65549095488     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)